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The adipose tissue-derived hormone, leptin, acts via its receptor (LRb) in the
brain to regulate energy balance and neuroendocrine function. In order to
understand leptin action we have explored the physiological function of LRb
signalling pathways, defining important roles for signal transducer and
activator of transcription-3 (STAT3) in positive signalling and for
LRbTyr985-mediated feedback inhibition in leptin signal attenuation. As the
cells on which leptin acts are not homogeneous, but rather represent a
broadly distributed network of neurones with divergent projections and
functions, it is also crucial to consider how each of these populations
responds to LRb signals to contribute to leptin action. While well-known
LRb-expressing neurones within the arcuate nucleus of the hypothalamus
mediate crucial effects on satiety and energy expenditure, other populations
of LRb-expressing neurones in the ventral tegmental area and elsewhere likely
control the mesolimbic dopamine system. Additional populations of LRb-
expressing neurones likely contribute to other aspects of neuroendocrine
regulation. It will be important to define the molecular mechanisms by which
leptin acts to regulate neurophysiology in each of these LRb-expressing
neural populations in order to understand the totality of leptin action.
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Leptin
The adipose tissue-derived hormone leptin is produced
in proportion to fat stores. Circulating leptin commu-
nicates the level of energy reserves in the periphery to
the central nervous system in order to suppress food
intake and permit energy expenditure (Friedman &
Halaas 1998, Bates & Myers 2003, Elmquist et al.
2005, Morton et al. 2006). Adequate leptin levels
permit energy expenditure on the processes of repro-
duction and growth, and similarly regulate other
elements of the endocrine and immune systems (Ahima
et al. 1996, Lord et al. 1998, Bates & Myers 2003).
Conversely, lack of leptin signalling as a consequence of
mutation of leptin (e.g. ob/ob mice) or the leptin
receptor (LR) (e.g. db/db mice) in rodents and humans
results in increased food intake in combination with
reduced energy expenditure (and thus obesity), plus
neuroendocrine dysfunction (including hypothyroidism,
decreased growth, infertility and decreased immune
function) (Montague et al. 1997, Clement et al. 1998,
Elmquist et al. 1998b, Friedman & Halaas 1998).
Many of the effects of leptin are attributable to effects
in the central nervous system (CNS), particularly in the
hypothalamus, a site of high LRb mRNA expression
(Elmquist et al. 2005, Morton et al. 2006).
Leptin receptors
A single Lepr gene directs the production of multiple
alternatively-spliced LR isoforms that are divisible into
three classes: secreted, short and long (Chua et al. 1997,
Tartaglia 1997). The secreted forms are either products
of alternatively spliced mRNA species (e.g. murine LRe,
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which contains only the first 14 exons of Lepr) or
proteolytic cleavage products of membrane-bound
forms of LR. These secreted forms contain only extra-
cellular domains that bind circulating leptin, perhaps
regulating the concentration of free leptin (Ge et al.
2002).
Short form LRs (including LRa in mice) and the single
long form LR (LRb in mice) possess identical extracel-
lular and transmembrane domains as well as the same
first 29 intracellular amino acids, but diverge in
sequence thereafter. Short form LRs terminate 3–11
amino acids after the splice junction for total intracel-
lular domain lengths of 32–40 amino acids. LRb
possesses an intracellular domain of approximately
300 residues and is the crucial receptor isoform for
leptin action (Chua et al. 1997, Tartaglia 1997).
Indeed, the originally described db/db mice lack LRb
(but not other LR forms) as a consequence of a
mutation that causes mis-splicing of the LRb mRNA;
these mice closely resemble db3J/db3J mice (which are
deficient in all LR isoforms) and leptin-deficient ob/ob
animals (Bates & Myers 2003). The function of short-
form LRs is less clear, although proposed roles include
the transport of leptin across the blood-brain barrier
and the production of circulating LR extracellular
domain to complex with leptin.
Leptin receptor signalling
LRb belongs to the interleukin (IL)-6 receptor family of
class 1 cytokine receptors, which contain an extracel-
lular ligand-binding domain, a single transmembrane
domain and a cytoplasmic signalling domain (Taga &
Kishimoto 1997, Tartaglia 1997). Like other cytokine
receptors, LRb does not contain intrinsic enzymatic
activity, but instead signals via a non-covalently
associated tyrosine kinase of the Janus kinase (JAK)
family – Jak2 in the case of LRb (Ihle & Kerr 1995,
Taniguchi 1995, Kloek et al. 2002). Leptin binding
alters the conformation of the preformed LRb homo-
dimer, enabling transphosphorylation and activation of
the intracellular LRb-associated Jak2 (Devos et al.
1997, Tartaglia 1997, Couturier & Jockers 2003).
The activated Jak2 molecule then phosphorylates other
tyrosine residues within the LRb/Jak2 complex to
mediate downstream signalling (White et al. 1997,
Banks et al. 2000, Hekerman et al. 2005).
Tyrosine kinase-dependent signalling generally pro-
ceeds via the phosphotyrosine-dependent recruitment of
signalling proteins that contain specialized phosphoty-
rosine-binding domains [e.g. Src homology 2 (SH2)
domains] (Koch et al. 1991). Each SH2 domain isoform
recognizes phosphotyrosine in a specific amino acid
context. Thus, while tyrosine phosphorylation acts as a
molecular switch to recruit SH2-containing proteins,
each tyrosine phosphorylation site recruits only specific
SH2 isoforms, as SH2 domains recognize the surround-
ing amino acids as well as the phosphotyrosine residue.
For instance, the SH2 domain of the latent transcription
factor, STAT3, binds to phosphotyrosine in the context
of a Y(P)XXQ motif (Songyang et al. 1993, Haan et al.
1999). Understanding signalling by the LRb/Jak2 com-
plex thus requires defining the tyrosine phosphorylation
sites on LRb and Jak2 and the SH2 proteins that they
recruit. There are three conserved tyrosine residues on
the intracellular domain of LRb – Tyr985, Tyr1077 and
Tyr1138 – and data from our laboratory and others
suggest that all these sites are phosphorylated and
contribute to downstream leptin signalling (Tartaglia
1997, White et al. 1997, Banks et al. 2000, Hekerman
et al. 2005) (and our unpublished data).
There are thus four primary intracellular signalling
pathways that emanate from LRb (Fig. 1) – those
originating directly from Jak2 tyrosine phosphorylation
sites plus those emanating from Tyr985, Tyr1077 and
Tyr1138 of LRb. The phosphorylation of Tyr985 creates
a binding site for the COOH-terminal SH2 domain of
the tyrosine phosphatase, SH2-containing tyrosine
phosphatase-2, aka PTPN II (SHP-2), leading to the
activation of the canonical p21ras fi ERK signalling
pathway in cultured cells (Banks et al. 2000, Bjorbaek
et al. 2001, Kloek et al. 2002).
Phosphorylation of Tyr1138 recruits STAT3 to the
LRb/Jak2 complex, resulting in the tyrosine phosphor-
ylation and subsequent nuclear translocation of STAT3
to mediate transcriptional regulation (White et al. 1997,
Banks et al. 2000). Among other genes, STAT3 medi-
ates the transcription of the SH2 domain-containing
feedback inhibitor, suppressor of cytokine signalling
(SOCS)-3 (Bjorbaek et al. 1998, Banks et al. 2000).
SOCS3 binds to Tyr985 of LRb to mediate inhibition of
LRb fi STAT3 signalling (Bjorbaek et al. 2000);
SOCS3 also binds to a separate site on Jak2 itself
(Sasaki et al. 2000).
Tyr1077 mediates a crucial component of STAT5
phosphorylation and transcriptional regulation by
leptin, although Tyr1138 also contributes to STAT5
activation (Hekerman et al. 2005, Gong et al. 2007).
Tyr1077 does not regulate STAT3 signalling, although it
may promote the increased phosphorylation of LRb
Tyr985.
Jak2 tyrosine phosphorylation during LRb stimula-
tion mediates some signals independently of tyrosine
phosphorylation sites on LRb, at least in cultured cells
(Banks et al. 2000). The individual phosphorylation
sites on Jak2 are beginning to be enumerated (Feng
et al. 1997, Carpino et al. 2002, Argetsinger et al.
2004, Feener et al. 2004, Kurzer et al. 2004, Matsuda
et al. 2004, Funakoshi-Tago et al. 2006, Ishida-
Takahashi et al. 2006), but many more remain to be
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identified. Unfortunately, the binding partners and
signals mediated by many Jak2 phosphorylation sites
remain unknown, limiting our understanding of the
mechanisms by which Jak2-dependent signals are med-
iated. LRb stimulation regulates the phosphatidylinosi-
tol 3¢-kinase (PI 3’-kinase), AMP-activated protein
kinase (AMPK) and mammalian target of rapamycin
(mTOR) pathways in the hypothalamus, and each of
these hypothalamic pathways contributes to the regu-
lation of feeding (Niswender et al. 2001, Minokoshi
et al. 2004, Xu et al. 2005, Cota et al. 2006, Plum et al.
2006). The mechanisms by which LRb controls these
pathways remain unclear, however.
LRb signalling via STAT3 mediates a subset
of leptin actions
Thus far, roles for two signals mediated by LRb tyrosine
phosphorylation sites have been examined in leptin
action in vivo: the Tyr1138 fi STAT3 pathway and the
Tyr985 fi SOCS3/SHP2 pathway (Fig. 1). We have
directly addressed the contribution of the LRb-STAT3
pathway to physiology by studying homologously
targeted ‘knock-in’ mice in which LRb is replaced by
a mutant molecule (LRbS1138) that contains a substitu-
tion mutation of Tyr1138 (the STAT3 binding site)
(Bates et al. 2003). Although LRbS1138 fails to mediate
activation of STAT3 during leptin signalling, this
mutant regulates all other LRb signalling pathways
normally. The use of the ‘knock-in’ approach ensures
that the expression pattern and levels of LRbS1138
mirror that of wild-type LRb.
Similar to db/db animals, mice homozygous for
LRbS1138 expression (s/s) display hyperphagia and
decreased energy expenditure, resulting in profound
obesity in the face of dramatically increased serum
leptin levels. The high circulating leptin levels in s/s
animals not only correlate with increased adipose mass
in these mice, but also indicate resistance to the energy
homeostatic effects of leptin (Bates et al. 2003).
Feeding is similarly high in s/s and db/db mice, and
thyroid function and energy expenditure are similarly
decreased in these two mouse strains (Bates et al.
2004).
However, important differences exist between the
phenotypes of s/s mice (missing only the LRb-STAT3
signal) and db/db mice (devoid of all leptin signals)
(Bates et al. 2003). Whereas db/db animals are floridly
Figure 1 Linking LRb signalling to the regulation of mammalian physiology. Shown is a schematic of cellular LRb signalling and
the roles of various signals in the regulation of physiology. Leptin binding to the extracellular domain of LRb activates the Jak2
tyrosine kinase that is constitutively associated with the intracellular domain of the receptor. This Jak2 activation results in the
tyrosine phosphorylation of various sites on Jak2 and three sites on the receptor, each of which regulates different signalling
pathways. LRb Tyr985 binds to SHP-2 to regulate the ERK pathway via GRB-2. Tyr1138 recruits STAT3 and contributes, along with
Tyr1077, to the activation of STAT5. STAT3 and STAT5 are each latent transcription factors that translocate to the nucleus during
LRb signalling to mediate transcriptional events. STAT3 prominently activates the transcription of the inhibitory SOCS3, which
attenuates LRb/Jak2 signalling by binding to Tyr985 and Jak2. Tyr1138 plays a prominent role in the regulation of satiety and
metabolic rate in vivo, while Tyr985 primarily attenuates LRb signalling. Neither of these sites are required for reproduction or
growth. The mechanisms by which LRb regulates other systems, including the mesolimbic dopamine/reward system and the immune
system, also remain unclear.
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diabetic, infertile and demonstrate decreased linear
growth, s/s mice exhibit greatly improved glucose
tolerance compared with db/db mice, retain relatively
normal gonad function and demonstrate increased
linear growth compared with wild-type animals (Bates
et al. 2003, 2004, 2005, Buettner et al. 2006). The
cellularity of the thymus and thrombosis in response to
vessel injury (both mediated by the effects of leptin on
haematopoietic-derived cells) are also enhanced in s/s
animals, though diminished in db/db mice (Bodary et al.
2002, 2007, Dunn et al. 2005).
Clearly, LRb fi STAT3-independent pathways medi-
ate a number of physiological responses to leptin. It is
also important to note, however, that the phenotype of
the s/s animals does not suggest the irrelevance of non-
STAT3 pathways in other aspects of energy balance,
only that STAT3 signalling is important for the regu-
lation of energy homeostasis. Thus, Tyr1138 fi STAT3-
independent signals may contribute to energy balance as
well as to the myriad other effects of leptin that are
normal in s/s mice.
LRb Tyr985 attenuates leptin action in vivo
In order to understand the contribution of LRb Tyr985
to leptin action and inhibition in vivo, we generated
mice in which LRb was homologously replaced by
LRbL985, which contains a non-phosphorylatable sub-
stitution mutation of Tyr985 that blocks SHP2/SOCS3
recruitment (Banks et al. 2000, Bjorbaek et al. 2000,
2001, Bjornholm et al. 2007). Mutation of Tyr985
in vivo results in reduced feeding and adiposity, and
increased baseline STAT3 activation in female l/l mice –
all in the face of low leptin levels. Coupled with the
increased sensitivity of l/l animals to exogenous leptin,
these observations suggest that mutation of Tyr985
blocks the activation of an inhibitory Tyr985-dependent
LRb signal, ultimately leading to increased leptin
sensitivity in vivo. These results suggest an important
role for Tyr985 in the attenuation of leptin action
in vivo, consistent with results from cultured cells that
suggest an important role for Tyr985 in the inhibition of
LRb signalling (Carpenter et al. 1998, Li & Friedman
1999, Bjorbaek et al. 2000).
As Tyr985 of LRb recruits both SHP-2 and SOCS3
(Carpenter et al. 1998, Li & Friedman 1999, Bjorbaek
et al. 2000), the failure of LRbL985 to recruit either of
these proteins could theoretically underlie the lean,
leptin-sensitive phenotype of l/l mice. However, most
data from cultured cells and animals support a primary
role for SOCS3 in the inhibition of LRb signalling
(Bjorbaek et al. 1998, 2000, 2001, Howard et al. 2004,
Mori et al. 2004, Zhang et al. 2004, Dunn et al. 2005).
SOCS3 mRNA expression was similar between +/+ and
l/l mice, suggesting the effect of LRb Tyr985 in the
attenuation of leptin action in vivo is not the result of
differences in SOCS3 expression.
The phenotype of l/l mice also suggests that SHP-2
may not be required for the regulation of growth or
reproduction by leptin and does not mediate essential
anorectic signals. This finding contrasts with the obesity
and impaired neuroendocrine function in animals with
deletion of SHP-2 in the forebrain (Zhang et al. 2004),
suggesting that disruption of SHP-2 alters signalling by
numerous factors other than leptin, and in a wide variety
of neuronal populations (Feng 1999, Keilhack et al.
2005). It is possible, however, that the loss of SHP-2
recruitment by leptin in l/l animals could result in a
diminution of anorectic function that is obscured by the
enhancement of overall LRb signalling due to the
concomitant loss of inhibitory signals in LRbL985.
Overall, however, LRb Tyr1138- and Tyr985-independent
signals probably contribute to the regulation of growth,
reproduction, haematopoietic function and glucose
homeostasis by leptin (Bates et al. 2003). The LRb
Tyr1077/STAT5 pathway, or signals mediated by the
LRb-associated Jak2 independently of LRb tyrosine
phosphorylation (Niswender et al. 2001, Bates & Myers
2003, Hekerman et al. 2005), are likely candidates to
mediate the control of these Tyr985/Tyr1138-independent
actions by leptin. Possible downstream pathways include
the PI 3¢-kinase, mTOR and AMPK pathways, although
other uncharacterized signals could also participate.
Leptin regulation of neural networks and
neurophysiology
LRb is present in several tissues, with the highest levels in
neurones of several nuclei of the hypothalamus, includ-
ing the arcuate (ARC), dorsomedial (DMH), ventrome-
dial (VMH) and ventral pre-mammillary (PMv) nuclei
and the lateral hypothalamic area (LHA) (Elmquist et al.
1998a, 2005, Baskin et al. 1999, Leshan et al. 2006,
Morton et al. 2006) (Fig. 2). Other sites within the brain
that have been shown to express functional LRb include
the ventral tegmental area (VTA), brainstem [including
the nucleus of the solitary tract (NTS)], and the
periaqueductal grey matter, among others.
LRb action in the ARC
Leptin action is particularly well characterized in two
populations of ARC neurones, both of which express
LRb. One population synthesizes neuropeptide Y (NPY)
and agouti-related peptide (AgRP) and the other
synthesizes pro-opiomelanocortin (POMC) (Elmquist
et al. 2005, Morton et al. 2006). POMC is processed to
produce a-melanocyte-stimulating-hormone (a-MSH)
in LRb/POMC neurones, which signals anorexia
(decreased appetite) by activating the melanocortin-4
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receptor (MC4R) and the melanocortin-3 receptor
(MC3R) (Huszar et al. 1997, Marsh et al. 1999, Butler
et al. 2000, Chen et al. 2000, Ste et al. 2000, Butler &
Cone 2002). LRb stimulates the synthesis of POMC and
activates/depolarizes LRb/POMC neurones (Cowley
et al. 2001, Elmquist et al. 2005, Morton et al. 2006).
NPY is an orexigenic (appetite-stimulating) hormone
that also suppresses the central LRb-mediated growth
and reproductive axes (Clark et al. 1985, Erickson et al.
1996, Elmquist et al. 2005, Morton et al. 2006). AgRP
is an antagonist of a-MSH/MC4R signalling as well as
an inhibitor (inverse agonist) of endogenous MC4R
activity (Ollmann et al. 1997, Elmquist et al. 2005,
Morton et al. 2006). Leptin acts via LRb to inhibit
NPY/AgRP neurones and suppress expression of these
neuropeptides (Cowley et al. 2001, Elmquist et al.
2005, Morton et al. 2006). Thus, LRb signalling
stimulates the production of anorectic neuropeptides
and suppresses levels of orexigenic peptides. Con-
versely, a decrease or deficiency in leptin activity
(e.g. during starvation and in ob/ob and db/db mice)
stimulates appetite by suppressing synthesis of anorectic
neuropeptides (e.g. POMC) and increasing expression
of orexigenic peptides (e.g. NPY and AgRP).
We have previously examined the regulation of ARC
neuropeptide expression and neuronal activity in s/s and
l/l mice. Similar to db/db mice, s/s mice have decreased
POMC mRNA levels in the hypothalamus (Bates et al.
2003). By contrast, whereas db/db animals display
dramatic induction of hypothalamic NPY mRNA, levels
of NPY message are near normal in s/s animals.
Furthermore, the activity of these AgRP/NPY neurones
is appropriately suppressed in s/s, but not in db/db
animals (Munzberg et al. 2007). These data suggest that
LRb-STAT3 signalling is a crucial regulator of hypo-
thalamic melanocortin action, and that dysregulated
melanocortin signalling (as opposed to alterations in
NPY) may contribute to the obesity of s/s animals,
although STAT3 presumably mediates other leptin
effects in other LRb-expressing neurones. In l/l mice,
levels of POMC mRNA are similar to those found in
wild-type mice, although levels of NPY and AgRP are
decreased in l/l animals, suggesting increased LRb
signalling in these animals and demonstrating that the
regulation of these neuropeptides is independent of
Tyr985. Hence, non-STAT3, non-Tyr985 LRb signals are
critical regulators of the LRb/NPY neurone.
LRb action beyond established ARC circuits
Although we now know a great deal about the
mechanisms by which the ARC NPY/AgRP and POMC
neurone function, numerous questions remain regarding
the magnitude of their contributions to the regulation of
Figure 2 A distributed network of LRb-expressing leptin responsive neurones. In addition to the well-known arcuate nucleus of the
hypothalamus (ARC), large populations of LRb-expressing neurones are found in a variety of other areas in the hypothalamus and
brainstem (filled ovals). Regions that receive important projections from LRb neurones but that do not themselves contain large
numbers of LRb neurones have white fills. Leptin action on LRb-expressing neurones in the ARC regulates neurones in the
paraventricular hypothalamic nucleus (PVH), the dorsomedial hypothalamic nucleus (DMH) and the brainstem, including the
nucleus of the solitary tract (NTS). These act, presumably along with LRb neurones within the DMH and NTS, to modulate satiety
(blue circuits). The mesolimbic dopamine system (orange/red circuits) encodes incentive salience and reward; at the core of this
system lie dopaminergic neurones in the ventral tegmental area (VTA) that project to the striatum and amygdala. Leptin regulates
this system directly via LRb-expressing dopaminergic and non-dopaminergic neurones in the VTA, as well as via lateral hypo-
thalamic (LHA) LRb neurones that project to the VTA to regulate dopamine production. Other areas containing less well
understood LRb neurones (grey ovals) include the pre-optic area (POA), ventromedial hypothalamic nucleus (VMH), ventral pre-
mammillary nucleus (PMv), periaqeductal grey (PAG), dorsal raphe (DR) and parabrachial nucleus (PB).
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feeding in response to leptin under physiological con-
ditions (Boston et al. 1997, Ellacott & Cone 2006).
Indeed, only 50% of ARC POMC neurones express
LRb (Munzberg et al. 2003). Also, although ablation of
AgRP neurones results in hypophagia and ablation of
POMC or central melanocortin receptors results in
severe obesity (Butler & Cone 2002, MacNeil et al.
2002), deletion of LRb from POMC neurones or the
restoration of LRb in the ARC of db/db animals results
in only modest alteration in body weight (Morton et al.
2003, Balthasar et al. 2004). Furthermore, although
interference with LRb fi STAT3 signalling in s/s mice
results in dramatic hyperphagia and obesity, deletion of
STAT3 in POMC and NPY/AgRP neurones only
modestly impacts body energy homeostasis (Bates et al.
2003, Kaelin et al. 2006, Xu et al. 2006). Thus, while
melanocortins and ARC POMC and NPY/AgRP neu-
rones generally effect powerful appetitive signals, leptin
is only one factor that regulates melanocortin action,
and thus these neurones may not mediate the majority
of the leptin-promoted anorectic signal. The aggregate
leptin signal is probably mediated in concert with many
other, currently uncharacterized, populations of LRb-
expressing neurones. Indeed, some data suggest the
existence of additional populations of ARC LRb
neurones, including those that are modified by cre
recombinase activity in rat insulin II gene prometer-Cre
(RIP-Cre) mice (Cui et al. 2004, Smith et al. 2007).
Arcuate LRb neurones comprise only 15–20% of the
total number of LRb-expressing neurones within the
CNS (Leshan et al. 2006), and other populations of
LRb neurones, including those in the VMH, and VTA
clearly mediate an important component of leptin
action (Dhillon et al. 2006, Fulton et al. 2006, Hommel
et al. 2006). Thus, unlike insulin, which acts primarily
on relatively homogeneous organs such as the liver and
muscle, leptin regulates a broadly distributed network
of LRb-expressing neurones in the brain in order to
orchestrate an array of neural processes that range from
neuroendocrine and sympathetic nervous system func-
tion, to satiety, and to the perception of food reward. It
is becoming increasingly clear that various facets of
leptin action are contributed to by discrete populations
of LRb neurones, and that the distributed network of
LRb neurones collectively mediates the totality of leptin
action.
Leptin regulation of satiety
Satiety is the perception of fullness that indicates that no
further food ingestion is needed. The ARC and VMH
are defined as ‘satiety centres’ because lesions of either
promote hyperphagia and obesity (Elmquist et al. 2005,
Morton et al. 2006). The contributions of the ARC to
leptin-mediated satiety (e.g. via LRb/POMC and
LRb/NPY) is well characterized, as discussed above.
VMH LRb neurones also contribute to satiety via
excitatory projections onto ARC POMC neurones
(Pinto et al. 2004, Sternson et al. 2005). The density
of these projections is dynamically regulated by leptin
availability (i.e. fasting or fed states) demonstrating the
exquisite sensitivity of the VMH to physiological
changes. At least one subpopulation of VMH LRb
neurones, those co-expressing the transcription factor
SF-1, is activated by leptin and contribute to leptin-
mediated satiety (Dhillon et al. 2006).
Several areas of the brainstem, including the NTS and
the area postrema, are also important for satiety
(Elmquist et al. 2005, Grill 2006, Morton et al. 2006).
The brainstem integrates numerous inputs from the gut
[including those from vagal afferents and the anorexi-
genic gut peptides glucagon-like peptide-1 (GLP-1) and
cholecystokinin (CCK)], as well as the hypothalamus, to
modulate satiety (Grill 2006). Leptin acts synergistically
with signals of gastric distension, GLP-1 and CCK to
regulate the neurones of the NTS, and thus contribute to
satiety (Morton et al. 2005, Williams et al. 2006, Huo
et al. 2007). The NTS and other brainstem regions
associated with satiety contain LRb neurones, and direct
leptin action on brainstem LRb-expressing neurones as
well as indirect leptin action via ARC LRb neurones that
project to the brainstem may contribute to the satiety
effects of leptin (Elmquist et al. 1998a, Grill et al. 2002,
Ellacott et al. 2006a,b, Grill 2006, Leshan et al. 2006,
Huo et al. 2007).
Leptin regulation of the mesolimbic
dopamine system
In addition to satiety, the rewarding properties of food
contribute to feeding (Kelley & Berridge 2002,
Figlewicz et al. 2006). For example, after ingestion of
a meal you may feel satiated (full), but may go on to eat
dessert because it seems appealing and tasty. Thus, the
reward value of food induces ingestion beyond what is
needed for satiety. Leptin regulates the reward value
placed on food (as well as of other addictive substances,
such as drugs of abuse) (Fulton et al. 2004, Carr 2006,
Figlewicz et al. 2006). Some of the neural mechanisms
by which leptin may control food reward are beginning
to be elucidated via the investigation of the interaction
of leptin with the mesolimbic dopamine (DA) system
(Figlewicz 2003, Figlewicz et al. 2003, Fulton et al.
2006, Hommel et al. 2006). The core of the mesolimbic
DA system lies in a set of DA neurones in the VTA that
project forward to innervate the striatum (nucleus
accumbens, caudate, putamen), amygdala and prefron-
tal cortex. It is by acting upon this system that drugs of
abuse generally exert their reinforcing effects, and the
activity of this system is clearly important to mediate
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the incentive salience of food and other natural rewards
(Kelley & Berridge 2002, Nestler 2005). The relation-
ship between the DA system and energy homeostasis has
been often described but is poorly understood. For
example, side effects of antipsychotic drugs (that act in
part as mixed DA antagonists) include weight gain and
metabolic disease (Bergman & Ader 2005).
While ARC LRb neurones do not project to the VTA,
systemic leptin administration modulates food reward,
suggesting a different locus for the regulation of DA
signalling (Figlewicz et al. 2006). A number of groups
have reported the presence of LRb-expressing VTA DA
neurones and demonstrated the ability of leptin to alter
the physiology of the DA system (Figlewicz 2003,
Figlewicz et al. 2003, Fulton et al. 2006, Hommel et al.
2006). Thus, leptin may act directly upon VTA LRb
neurones to regulate DA synthesis and release in the
striatum and amygdala.
The lateral hypothalamic ‘feeding’ centre interacts
extensively with the mesolimbic DA system to regulate
motivation and reward, including food reward (Kelley
& Berridge 2002, DiLeone et al. 2003, Fulton et al.
2004). Furthermore, states of nutritional deficiency
modulate rewarding intrahypothalamic self-stimulation
(IHSS) in the perifornical area of the LHA (Fulton et al.
2004). LHA orexin neurones project to the VTA and
regulate drug and food-associated reward signalling,
and LHA melanin-concentrating hormone (MCH) neu-
rones interact with the striatum (DiLeone et al. 2003,
Harris et al. 2005).
The LHA is another important locus of leptin action
on the DA system. Leptin inhibits the activity of orexin
neurones and reduces the expression of the LHA
neuropeptide MCH, as well as attenuating IHSS (Qu
et al. 1996, Fulton et al. 2000, 2004, Yamanaka et al.
2003). Inhibition of OX and MCH signalling via their
respective receptor antagonists inhibit food intake and
modulate DA signalling in rodent models similar to
leptin, and these pathways are thus potential drug targets
for anxiety and weight loss. We have also identified a
novel population of LRb-expressing neurones in the
LHA that project to the VTA to regulate the mesolimbic
DA system (our unpublished data). As in the ARC, these
LHA LRb neurones are composed of multiple different
subpopulations of neurones that are divergently regu-
lated by leptin and other nutritional factors. Thus, leptin
acts via multiple ARC-independent systems to control
the VTA and the mesolimbic DA system at its inception
in the VTA, and these sites of leptin action probably
regulate the incentive salience of food.
Summary
The totality of leptin action neither reflects the output of
a single intracellular signal nor that of a single (e.g.
ARC) neural circuit, but rather integrates multiple LRb-
stimulated signals acting in concert upon a widely
distributed and heterogeneous array of LRb-expressing
neurones. The spatial diversity along with the distinct
complements of neurotransmitters employed by these
myriad LRb-expressing neural populations suggests the
divergent function of many subpopulations of LRb
neurones even within the discrete LRb-expressing brain
regions. It will be important to understanding the
phenotype (neural inputs and outputs; neurotransmit-
ters) of each distinct population of LRb-expressing
neurones and the roles for the various LRb-mediated
signals in each set of neurones in order to truly
understand the mechanisms of leptin action. This
information is likely to reveal not only novel informa-
tion about leptin action, but also potential novel targets
for the regulation of feeding and the treatment of
obesity.
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